Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes Vikas S. SridharChristine P. LimonteDavid Z. I. Cherney Review 06 October 2023 Pages: 3 - 18
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia Willemijn E. CorpeleijnWouter J. de WaalAlbert Wiegman Review Open access 30 November 2023 Pages: 19 - 26
A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab Chantal MathieuAlice Wiedemanon behalf of the AG019-T1D-101 Trial Investigators Article Open access 02 October 2023 Pages: 27 - 41
Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes Ting ZhongBinbin HeXia Li Article 27 October 2023 Pages: 42 - 51
Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial Linda C. A. DrenthenJeroen H. F. de BaaijBastiaan E. de Galan Article Open access 03 November 2023 Pages: 52 - 61
Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data Infrastructure Nicholas BowdenRachael DixonBenjamin J. Wheeler Article Open access 23 October 2023 Pages: 62 - 73
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT) Laura J. CorbinDavid A. HughesNicholas J. Timpson Article Open access 25 October 2023 Pages: 74 - 87
The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes Dong Hoon LeeQi JinFred K. Tabung Article 11 October 2023 Pages: 88 - 101
Multi-omic prediction of incident type 2 diabetes Julia Carrasco-ZaniniMaik PietznerNicholas J. Wareham Article Open access 27 October 2023 Pages: 102 - 112
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq Shenali A. AmaratungaTara Hussein TayebJan Lebl Article Open access 28 October 2023 Pages: 113 - 123
Apolipoprotein L genes are novel mediators of inflammation in beta cells Miriam Paz-BarbaAmadeo Muñoz GarciaFrançoise Carlotti Article Open access 04 November 2023 Pages: 124 - 136
Adjudin improves beta cell maturation, hepatic glucose uptake and glucose homeostasis Lipeng RenJérémie CharbordOlov Andersson Extended Article Open access 16 October 2023 Pages: 137 - 155
Novel time-resolved reporter mouse reveals spatial and transcriptional heterogeneity during alpha cell differentiation Miwa HimuroYuka WakabayashiTakeshi Miyatsuka Article 23 October 2023 Pages: 156 - 169
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis Kavaljit H. ChhabraSiresha BathinaAutumn Davis Extended Article Open access 15 September 2023 Pages: 170 - 189
Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study Jackie ElliottGordon Sloanfor the EURODIAB Prospective Complications Study Group Article Open access 23 October 2023 Pages: 190 - 198
Non-invasive imaging of sympathetic innervation of the pancreas in individuals with type 2 diabetes Achyut Ram VyakaranamMaryama M. MahamedAnders Sundin Article Open access 07 November 2023 Pages: 199 - 208
Sex influences health: reporting on female characteristics should be mandatory in exercise and physical activity-related diabetes research Jane E. YardleyAlexa GovetteJenna B. Gillen Letter 05 October 2023 Pages: 209 - 210
Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes Francois G. RollinColin WashingtonShelly-Ann Fluker Letter 07 September 2023 Pages: 211 - 212
Using race as a social construct when looking at differences in racial associations between non‑alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter] Yu HatanoLisa B. VanWagnerYuichiro Yano Letter 26 October 2023 Pages: 213 - 214
Correction to: Pancreatic T cell protein–tyrosine phosphatase deficiency affects beta cell function in mice Yannan XiSiming LiuFawaz G. Haj Correction 20 October 2023 Pages: 215 - 215
Correction to: Cell-autonomous programming of rat adipose tissue insulin signalling proteins by maternal nutrition Malgorzata S. Martin-GronertDenise S. Fernandez-TwinnSusan E. Ozanne Correction Open access 06 November 2023 Pages: 216 - 217
Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation Beatriz MerinoElena Casanueva-ÁlvarezIrene Cózar-Castellano Correction Open access 15 November 2023 Pages: 218 - 219
